{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "01041037",
    "licUnit": "1",
    "validDate": "2028-09-18 00:00:00.000",
    "issueDate": "1998-09-18 00:00:00.000",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHY00104103702",
    "prodNameC": "力得微脂體注射劑2毫克\/毫升（鹽酸杜薩魯比辛）",
    "prodNameE": "LIPO-DOX LIPOSOME INJECTION 2MG\/ML(DOXORUBICIN HYDROCHLORIDE)",
    "indicationsName": [
        "用於治療CD4數量低下(<200 CD4 LYMPHOCYTES\/MM3）和黏膜、皮膚或內臟有病變的AIDS RELATED KAPOSI'S SARCOMA的病人。用於治療曾接受第一線含鉑類藥物(PLATINUM-BASED)化學治療而失敗者或再復發之進行性或轉移性卵巢癌病人。可用於單一治療有心臟疾病風險考量之轉移性乳癌患者。可與bortezomib併用治療於曾接受過至少一種治療方式且已經接受或不適宜接受骨髓移植的進展性多發性骨髓瘤病人。"
    ],
    "does": "2270",
    "packageUnit": [
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        },
        {
            "packageSpec": "5\/10公撮",
            "packageUnit": "13"
        }
    ],
    "medMCode": "05",
    "maMedCode": null,
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "46C6F42A-C175-43EF-BBA1-6083E8158C5A",
    "subCategory": [],
    "ingredientsDesc": [
        "DOXORUBICIN HYDROCHLORIDE(LIPOSOME)"
    ],
    "restraintItemsCode": [
        "01"
    ],
    "applicantName": "台灣東洋藥品工業股份有限公司",
    "applicantAddr": "台北市南港區園區街3之1號3樓",
    "medClass": null,
    "efficacy": "． ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "臺灣東洋藥品工業股份有限公司中壢廠",
            "factoryAddr": "桃園市中壢區中華路一段８３８號",
            "factoryCompanyAddr": "",
            "countryCode": "TW",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "1406804300",
            "factoryInfo": null,
            "qsd": null,
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1003000615",
            "ingredientsName": "DOXORUBICIN HYDROCHLORIDE(LIPOSOME)",
            "ingredientsDesc": "DOXORUBICIN HYDROCHLORIDE(LIPOSOME)",
            "concentDesc": "(POTENCY)",
            "concent": "2.0000",
            "concentUnit": "001",
            "seq": "0",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [
        {
            "applicantName": "信撰股份有限公司",
            "certNo": "DHY00104103724",
            "approveDocNo": "1120725406",
            "authDate": "2023-10-20",
            "validDate": "2028-04-30"
        }
    ],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01DB01"
        }
    ],
    "licBaseId": "B6734BE8-B4BD-40F4-9367-D95F8B452ECE"
}